Emerg Infect Dis. 2023 Sep;29(9):1789-1797. doi: 10.3201/eid2909.230052.
Brucellosis is a major public health concern worldwide, especially for persons living in resource-limited settings. Historically, an evidence-based estimate of the global annual incidence of human cases has been elusive. We used international public health data to fill this information gap through application of risk metrics to worldwide and regional at-risk populations. We performed estimations using 3 statistical models (weighted average interpolation, bootstrap resampling, and Bayesian inference) and considered missing information. An evidence-based conservative estimate of the annual global incidence is 2.1 million, significantly higher than was previously assumed. Our models indicate Africa and Asia sustain most of the global risk and cases, although areas within the Americas and Europe remain of concern. This study reveals that disease risk and incidence are higher than previously suggested and lie mainly within resource-limited settings. Clarification of both misdiagnosis and underdiagnosis is required because those factors will amplify case estimates.
布鲁氏菌病是全球主要的公共卫生关注点,特别是对生活在资源有限环境中的人而言。从历史上看,全球人类病例的年度发病率的循证评估一直难以捉摸。我们利用国际公共卫生数据,通过将风险指标应用于全球和区域高危人群,填补了这一信息空白。我们使用了 3 种统计模型(加权平均插值、引导重采样和贝叶斯推断)进行了估算,并考虑了缺失信息。基于证据的全球年度发病率保守估计为 210 万,明显高于之前的假设。我们的模型表明,非洲和亚洲承担着全球大部分风险和病例,但美洲和欧洲的某些地区仍令人担忧。本研究表明,疾病风险和发病率高于先前的估计,主要集中在资源有限的环境中。由于这些因素会放大病例估计,因此需要明确误诊和漏诊的情况。